Skip to contents
In This Issue:
The Mohs Surgery Center recently moved from the Dana-Farber Cancer Institute to Faulkner Hospital, and BWH and Faulkner marked the event with an open house last month.
Adding to services available at the Dana-Farber/Brigham and Women’s Cancer Center at Faulkner, the Mohs Center will continue its rich tradition of delivering highly-specialized outpatient treatment for skin cancers to patients in its new suite on the fourth floor at Faulkner, a site with three times as much space.
The new Mohs suite is licensed by BWH and managed by the Department of Dermatology. The DF/BWCC at Faulkner also offers programs in breast, thoracic and gastrointestinal cancers, as well as general oncology.
Mohs micrographic surgery is a highly specialized technique for removing skin cancer. It has become the standard of care for selective facial skin cancer. Developed in the 1940s by Frederick Mohs, MD, the layered approach involves surgically removing the cancer and underlying tissue, freezing and marking the removed tissue with dye and immediately analyzing it under a microscope to pinpoint any remaining cancer.